The BTB program can provide up to $1 million of funding over a maximum two-year year period to nurture early stage health and medical research to reach proof-of-concept stage with potential to attract further capital and support.
We are expecting the second round of the MRFF Biomedical Translation Bridge (BTB) Program to open in Early February. This is a 2 stage process. An EoI first, and then you may be invited to submit a full application. The turn-around time on EoIs is expected to be short so you will need to start to prepare now if you are interested in this call.
For details slides, guidelines of the scheme please see:
https://www.mtpconnect.org.au/projects/biomedicaltranslationbridgeprogram
On that page you will also see what was funded in round 1 as a guide to what success looks like.
IMPORTANT: This is a leverage scheme.
You MUST have dollar-for-dollar matched funding from another source (usually industry, cannot be another Commonwealth Grant).
Biocurate is a Venture Partner in the BTB Program but is also an early stage VC company owned by Monash and UniMelb. They will be running a Special Briefing and Q&A for Monash/Monash Partners on Monday 10, February.
There are 2 sessions to choose from. Zoom will also be available.
Session 1:
Venue: Monash Clayton campus Room D523, Level 5, 35 RainForest Walk (Old Biochem building)
Date: Monday 10th February 2020, 9:30 AM – 10:30 AM
Session 2:
Venue: Monash Institute of Pharmaceutical Sciences Dean's Meeting Room, G19, Ground Floor, 399 Royal Parade, Parkville
Date: Monday 10th February 2020, 3:30 PM – 4:30 PM
Please RSVP to Karen McConalogue by return email if you are interested in attending. Please let Karen know which session you are interested in and if you require Zoom.
No comments:
Post a Comment